文献速递糖尿病肥胖与代谢综合征

代谢功能障碍相关脂肪性肝病改变肝脏和脂肪组织的脂肪酸谱

Metabolic Dysfunction-associated Steatotic Liver Disease Alters Fatty Acid Profiles in the Liver and Adipose Tissue.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

研究比较了183例重度肥胖患者肝脏、血清、内脏和皮下脂肪组织的脂肪酸组成,这些患者肝脏正常、仅有单纯性脂肪变性或患有代谢功能障碍相关脂肪性肝炎(MASH)。MASH患者肝脏多不饱和脂肪酸比例显著低于肝脏正常者,而脂肪组织中二高γ-亚麻酸、肾上腺酸和花生四烯酸比例较高。结论指出MASH患者肝脏多不饱和脂肪酸含量降低、饱和脂肪酸升高、n6与n3多不饱和脂肪酸比值升高,而脂肪组织未见明确趋势。

要点

  • MASH患者肝脏多不饱和脂肪酸比例显著低于肝脏正常者(均校正P<0.01)。
  • MASH患者脂肪组织中二高γ-亚麻酸、肾上腺酸和花生四烯酸比例较高(均校正P<0.001)。
  • MASH患者肝脏饱和脂肪酸升高、n6与n3多不饱和脂肪酸比值升高,脂肪组织无明确趋势。

核心结论

  • MASH患者肝脏多不饱和脂肪酸含量降低、饱和脂肪酸升高、n6与n3多不饱和脂肪酸比值升高,而脂肪组织未见明确趋势。
  • 这些发现强调MASLD中肝脏与脂肪组织脂肪酸代谢存在差异,提示组织特异性调控机制。

研究设计与样本

  • 研究纳入183例重度肥胖患者(122例女性,平均年龄46.9±9.7岁,体重指数43.5±5.7 kg/m2),在腹腔镜胃旁路术中采集术前血清、肝脏、皮下和内脏脂肪组织样本。
  • 采用气液色谱法分析脂肪酸组成,使用Kruskal-Wallis检验比较不同组织库的脂肪酸比例。

主要发现

  • MASH患者肝脏中多不饱和脂肪酸比例显著低于肝脏正常者(均校正P<0.01)。
  • MASH患者脂肪组织中二高γ-亚麻酸、肾上腺酸和花生四烯酸比例较高(均校正P<0.001)。
  • MASH患者肝脏脂肪酸比例变异大于脂肪组织。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The alterations in systemic fatty acid (FA) metabolism in metabolic dysfunction-associated steatotic liver disease (MASLD) remain unclear. OBJECTIVE: To investigate intertissue crosstalk in FA metabolism in patients with MASLD, we compared FA profiles in the liver, serum, visceral, and subcutaneous adipose tissue of patients with severe obesity and normal liver, simple steatosis, or metabolic dysfunction-associated steatohepatitis (MASH). METHODS: Preoperative serum, liver, subcutaneous, and visceral adipose tissue samples were collected during laparoscopic gastric bypass surgery from 183 patients with severe obesity (122 women, mean age 46.9 ± 9.7 years, body mass index 43.5 ± 5.7 kg/m2). FA composition was analyzed using gas-liquid chromatography. The Kruskal-Wallis test was used to compare the FA proportions in different tissue depots. RESULTS: FA proportions varied more in the liver than in adipose tissue in patients with MASH. Polyunsaturated FAs (PUFA) proportions were significantly lower in the livers of patients with MASH than in those with normal livers (all adjusted P < .01). Conversely, dihomo-gamma-linolenic acid, adrenic acid, and arachidonic acid proportions were higher in the adipose tissues of patients with MASH (all adjusted P < .001). CONCLUSION: Patients with MASH exhibited reduced hepatic PUFA content, increased hepatic saturated FAs, and a higher n6-to-n3 PUFA ratio, whereas no clear trends were observed in adipose tissue. These findings highlight distinct differences in FA metabolism between the liver and adipose tissue in MASLD, emphasizing tissue-specific regulatory mechanisms.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Palomurto S, Virtanen KA, Kärjä V, et al. Metabolic Dysfunction-associated Steatotic Liver Disease Alters Fatty Acid Profiles in the Liver and Adipose Tissue. J Clin Endocrinol Metab. 2025. PMID: 40503664. doi:10.1210/clinem/dgaf346

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。